Antibody neutralization studies have established interferon qr (IFN-3') as a critical mediator of endotoxic shock. The advent of IFN-3, receptor negative (IFN3,R-/-) mutant mice has enabled a more direct assessment of the role of IFN-'y in endotoxin (lipopolysaccharide [LPS]-induced shock. We report that IFN3'R-/-mice have an increased resistance to LPS-induced toxicity, this resistance manifesting well before the synthesis and release of LPS-induced IFN-% LPSinduced lymphopenia, thrombocytopenia, and weight loss seen in wild-type mice were attenuated in IFN3,R-/-mice. IFN3,R-/-mice tolerated 100-1,000 times more LPS than the minimum lethal dose for wild-type mice in a D-galactosamine (D-GalN)/LPS model. Serum tumor necrosis factor (TNF) levels were 10-fold reduced in mutant mice given LPS or LPS/D-GalN. Bone marrow and splenic macrophages from IFN'yR-/-mice had a four-to sixfold decreased LPS-binding capacity which correlated with similar reduction in CD14. Serum from mutant mice reduced macrophage LPS binding by a further 50%, although LPS binding protein was only 10% reduced. The expression of TNF receptor I (p55) and II (p75) was identical between wild-type and mutant mice. Thus, depressed TNF synthesis, diminished expression of CD14, and low plasma LPSbinding capacity, in addition to blocked IFN-3' signaling in the mutant mice, likely to combine to manifest in the resistant phenotype of IFN'yR-/-mice to endotoxin.
T he gram-negative bacterial wall constituent, endotoxin (LPS)., is the major active agent in the pathogenesis of septic shock (1) . A shocklike state can be induced by a single injection of LPS into animals. This toxic syndrome, initiated after the entrance of LPS into the circulation, is mediated by macrophage-derived inflammatory cytokines. TNF-ot appears to play a central role in the pathogenesis, as indicated by the inhibition of LPS-induced toxicity, by neutralizing anti-TNF-ot antibodies (2, 3) by and the deletion of the TNFtype I receptor (4, 5) .
IFN-'y exerts antiviral and immunostimulatory effects through macrophage and NK cell stimulation, and upregulates the expression of MHC class II antigens. IFN-y is produced by activated T lymphocytes and NK cells and exerts its biologic activity through binding a unique cell surface receptor (6, 7) . In previous investigations, it was shown that the administration of IFN-~" or neutralizing antibodies to IFN-3' modified the lethal outcome in several forms of endotoxic shock and gram-negative bacterial infections (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , clearly implicating its importance at the time of its synthesis in the pathogenesis of endotoxic shock.
The recent generation of IFN~/R-deficient mice (18, 19) has allowed improved definition of the in vivo influence of IFN-'y on TNF production and endotoxic shock. We report that the absence of functional IFN-'y signaling in IFN'ylk-/-mice markedly reduces LPS-induced toxicity. Key observations contributing to this LPS resistance were lowered serum TNF levels and diminished expression of LPS receptors on macrophages/monocytes.
Materials and Methods
Animals. 7-10-wk-old 129 SV wild-type and IFN'yR-/-mice bred in our animal facility (Institute of Toxicology of the Swiss Federal Institute of Technology) were used. Experimental groups consisted of 5-10 mice. The generation of these mice was recently described (18) .
Reagents. LPS from Escherichia coli (serotype Ol11:B4) and FITC-conjugated LPS (serotype 0111:B4) were purchased from Sigma Chemical Co. (St. Louis, MO) and resuspended in pyrogenfree sterile saline. Rat anti-mouse monocyte-macrophage IgG (F4/80) was obtained from the American Type Culture Collection (Rockville, MD). Rat anti-mouse MAC-1 was purchased from BMA Biomedicals (Augst, Switzerland). Goat anti-rat IgG conjugated to PE was from Southern Biotechnology Associates (Birmingham, AL). Rabbit anti-mouse TNFR I (p55) and II (p75) was the generous gift of Genentech (South San Francisco, CA). Rabbit anti-murine CD14 antibody was produced in the laboratory of Dr. Didier Heumann. D-galactosamine hydrochloride (DGalN) 1 (Carl Roth GmbH & Co., Karlsruhe, Germany) was dissolved in saline immediately before use.
Determination of Serum TNF and LPS Binding Protein. Blood samples were obtained by retroorbital venipuncture. Serum concentrations of TNF were estimated by a cytotoxicity assay with WEHI-164 clone 13 cells as previously described (20) . Results were expressed in nanograms per milliliter in reference to the cytotoxic activity of standard murine TNF-cr LPS binding protein (LPB) was determined by RIA as described (21 
Results and Discussion
Abundant evidence for the pathogenic roles of TNF and IFN-3, in endotoxic shock and gram-negative infections has been obtained primarily through demonstration of protective effects after antibody neutralization of these cytokines (2) (3) (4) (5) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . The advent of mice deficient in their response to single cytokines has enabled the closer examination of potential toxic interactions between these cytokines. This latter approach has unequivocally identified TNF as a central mediator of endotoxic shock (4, 5) . We present evidence confirming that IFN-3/is a key regulator of LPS toxicity. Although IFN-'y protein and mRNA peak levels occur only 4-6 h after LPS administration (13, 22, 23) we demonstrate mitigated toxicity already at 1 h after injection (reduced weight loss and thrombocytopenia) with marked differences at 6 h, suggesting the presence of important IFN-3~-mediated or primed signaling events early in the development of the toxic state. We therefore examined parameters likely to be of early pathogenic importance in order to elucidate the marked resistance of the IFN3~R-/-mice to endotoxin.
Resistance to Endotoxic Shock of lFNTR-/-Mice. Wildtype mice receiving only 10/zg LPS appeared distressed and had watery diarrhea within 6 h of LPS injection, whereas IFN3~R-/-mice tolerated up to 100 #g without demonstrating clinical changes. At LPS doses ~>500 /~g dosedependent differences are lost between IFN'yR-/-and IFN3~R+/+ mice (data not shown), as is also the case for TNFRI (P55) deficient mice and their wild-type counterparts (4). Correlating with clinical appearance was a weight loss, already apparent at 1 h in the 100-#g wild-type group (data not shown), which was marked at 24 h (Fig. 1) . A severe weight loss (10% of body weight) was registered at 24 h in wild-type mice receiving the two highest LPS doses (p <0.02 wild-type versus mutant mice). Body weight loss was referable to severe dehydration due to diarrhea.
Mice from all groups treated with LPS became leukopenic to a similar degree of severity within 1 h of LPS injection (Fig. 2 A) . The leukopenia observed at 6 h comprised a severe absolute lymphopenia, monocytopenia, disappearance of eosinophils from peripheral blood, and an absolute neutrophilia (Table 1 ). This leukocyte pattern was independent of dose (data not shown). Neutrophila was more pronounced and leukocytosis less severe in negative mice (p <0.05) ( Table 1) . Hematologic alterations were similar in mice treated with LPS alone or with LPS and o-GaiN (data not shown). Marked toxic change with basophilic coloration, fine vaculation and DShle bodies, and a left shift with stages to metamyelocytes was evident in neutrophils of mutant and normal mice. The recovery of total leukocyte counts at 24 h was significantly more rapid in IFN'yR-/-mice than in wild-type mice (t9 <0.02) with a clear trend apparent at 6 h (Fig. 2 A) .
Thrombocytopenia was already evident at 1 h, with levels dropping progressively for 24 h in wild-type mice (p <0.05), whereas most IFN'yR-/-mice reached nadir at 6 h with mild recovery of platelet number being observed at 24 h (Fig.  2 B) . Thus, in the absence of a functional IFN'yR system, hematologic and clinical signs of LPS toxicity are mitigated. The higher neutrophil count in LPS-treated IFN'yR-/-mice probably reflects reduced extravasation of neutrophils in response to reduced production of chemokines (IL-8-1ike peptides). TNF levels are reduced and IFN-'y is nonsignaling in IFN3'R-/-mice; both are critical signals for the induction of chemokine synthesis and secretion in extravascular tissues (24) .
IFNTR-/-Mice Are Resistant to Endotoxic Shock and Hepatocellular Necrosis in the D-GalN Model.
Wild-type mice administered >t0.1 #g LPS in combination with o-GaiN succumbed to acute liver failure 6-24 h after injection. In sharp contrast, 10 #g LPS with D-GaIN was lethal for only 25% of IFN'yK-/-mice (Table 2) . Thus, 100-1,000 times more LPS was required to produce an equivalent outcome in IFN'yR-/-mice. The degree of protection observed in the TNFR I-deficient mice with the LPS/D-GalN model (4, 5) is similar to that of the IFND/R-/-mice in this study. 100-fold enhancement of sensitivity to LPS injection achieved through chronic bacille Calmette-Gu&in (BCG) infection was also recently used to demonstrated protection from lethality in IFND/R-/-mice (25) . Alanine (ALT) and aspartate (AST) aminotransferases, enzyme markers of hepatocellular necrosis, were elevated in all wild-type mice after 6 h of LPS treatment, an effect significantly reduced in IFND'R-/-mice ( Table 3 ). The elevation of ALT and AST seen in staphylococcal enterotoxin (SEB)-treated IFN'rR+/+ mice was completely suppressed in IFND~R-/-mice ( Table 3 ), suggesting that T cell activation-induced systemic toxicity is an event mediated at least in part through the IFNyR, as well as partly through the TNFRI, since similar protection was also observed in SEB-treated TNFRI deficient mice (5) . Markedly elevated aminotransferases in wild-type animals were associated with a destruction of hepatocytes, characterized by widespread pyknosis and karyorrhexis of hepatocyte nuclei, and cellular fragmentation (Fig. 3 A) . Surviving IFND, R-/-mice demonstrated only mild microvacuolar centrilobular degeneration and some cell dropout (Fig. 3 B) . Since liver failure was markedly attenuated in IFND~R-/-mice, IFNyR-receptordependent events are clearly important for the generation of the acute liver necrosis in LPS/D-GalN toxicity.
LPS-induced Serum TNF Levels in IFNTR-/-Mice Are
Reduced. LPS administered together with D-GaIN induced a significant, dose-dependent synthesis and release of TNF in all animals, which was 10-fold less in IFND~R -/-mice (Fig. 4 A) . This clear difference was restricted to doses of LPS ~<30 #g per mouse. Lack of clear dose-responsive toxicity at high LPS levels was also observed in TNFRI mice (4) . Similar TNF levels were obtained in mice injected with LPS alone (Fig. 4 B) . Since serum TNF was not detectable 4 h after injection in either wild-type or IFND/R-/-mice, delayed synthesis can be excluded. After chronic BCG infection and subsequent LPS sensitization, LPS treatment (25 #g per mouse) was recently shown to result in synthesis of TNF-cx and IL-lo~, 100-and 12-fold lower in IFND'R-/-mice, respectively (25) . The observation that neutralization of IFN-3/in mice immediately before infection with E. coli reduced mortality without decreasing TNF levels, but that administering of IFN-3~ enhanced both mortality and TNF, suggests that the mechanism of TNF inhibition in IFND/R-/-mice is perhaps different than that documented for antibody neutralization, and at least in models using live bacteria, IFN-3/ alone rather than TNF and IFN-3/is critical in determining All AST ALT results represent mean values _+ SE from five to eight animals. Experiment was repeated three times with consistent outcome (typical experiment given, same as Table 2 mortality (16, 17) . The deficiency status of the I F N 3 , R -/ -mice would interrupt any homeostatic mechanisms dependent on IFN-3' more thoroughly than short-term antibody neutralization, and likely resulted in the loss of priming mechanisms necessary for the normal production of T N F in this study. Previous investigations have shown that LPS-stimulated macrophages produce increased amounts of TNF when treated concomitantly with IFN-% which is regulated at the the level of T N F gene transcription and possibly of m R N A stability (26) (27) (28) (29) . IFN-'y reportedly enhances the expression of T N F R on several cell types by three-to fivefold (30) (31) (32) . Since T N F induces its own synthesis in macrophages (33) , low expression of T N F R could have potentially contributed to deficient TNF synthesis in I F N ' y R -/ -mice, however flow cytometric analyses of TNFILI and II (Table 4) showed a remarkably consistent level of receptor expression between mutant and wildtype mice. The possibility that reduced T N F production in I F N 3 ' K -/ -mice was referable to decreased numbers of fixed macrophages was addressed by performing immunohistochem-
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Impaired Macrophage Recognition of LPS by IFN'yR-/-Mice.
Since TNF levels were higher in wild-type mice, and
given that TNF appears much earlier (1 h) than IFN-3, (4-6 h) in an endotoxic shock response (13, 22, 23) , it appeared likely that monocyte-macrophages of wild-type mice were more sensitive to LPS than their mutant counterparts, particularly since equivalent numbers of monocytes are present in wild-type and IFNyR-/-mice (18) . We examined the binding of LPS-FITC to spleen and bone marrow macrophages in the presence and absence of plasma pooled from untreated wild-type mice, in light of the recent reports that LPB enhances the binding of LPS to the murine CD14 receptor (34, 35) . Wild-type macrophages possessed a four-to sixfold higher binding capacity for LPS-FITC than macrophages from IFNyR-/-mice ( Fig. 5 A, p <0 .05). Consistent with this result was a four-to sevenfold higher CD14 expression (Table  4) . Macrophages demonstrated LPS-FITC binding that was markedly enhanced by the presence of plasma (Fig. 5 B) , and inhibitable by anti-CD14 antisera (data not shown). These results suggest an apparent in vivo upregulation of the CD14 receptor by the low levels of IFN-3, presumably present normally in mice, which contrasts in vitro with data showing that human IFN-3, is able to markedly downregulate the expression of human monocyte CD14, particularly in the presence of LPS (36, 37) . This downregulation is likely a high dose-dependent effect that, after the systemic release of IFN-3' in the presence of LPS, contributes to the turning off of LPS-mediated events.
Plasma-mediated enhancement of LPS-FITC binding was more than 50% reduced in macrophages preincubated with pooled plasma from IFNyR-/-mice (Fig. 5 B) , suggesting that LPB is also reduced in these mice. RIA for LPB from a serum pool of eight positive mice, however, yielded 2.2 _+ 0.2 #g/ml, and that of negative mice, 2.0 + 0.3 #g/ml, which does not explain the observed reduction of LPS-FITC binding. This may suggest the presence of additional factors in murine plasma capable of promoting LPS-binding to macrophages. LPS-FITC binding was restricted to F4-80 positive macrophages, which also expressed MAC-1 (CD11b). Downregulation of CD14, LPB function, and the mechanism of reduced TNF synthesis in IFN'yR-/-mice are presently under investigation.
In conclusion, we report that the toxicity of LPS is significantly reduced in IFNq, R-/-mice, which are able to withstand the deleterious effects of 100-1,000 times more LPS in the D-GaIN sensitization model than wild-type mice. The combination of defects present in IFNq, R-/-mice, including reduced TNF synthesis, impaired LPS recognition due to diminished CD14 expression and plasma-facilitated receptor binding, and blocked IFN-3' signaling, act in concert to seriously impair LPS-induced toxicity.
